Research on Clinical Evaluation and Technical Operation Standardization of Tangbi Waixi Decoction in Treating Patients with Diabetic Peripheral Neuropathy

Conditions

Diabetic Peripheral Neuropathy

Huang HY, Lin YP, Wei H, Fu Y, Zhou YH, Fang ZH, Qiu XT, Wang M, Li QB, Li SS, Wang SD, Dai F, Liu ZJ, Zhao L, Wen JX, Wu LY, Zeng HY, Zhang JM, Lu QY, He L, Song W, Sun L, Luo LL, He JL, Xie WW, Liang QS, Huang Y, Zhu SL, Long JE, Gao ZJ, Wen ZH, Li CJ, Ouyang WW, Li G, Wu MH, Li AX, Huang JZ, Paul SK, Tang XY, Fan GJ.

2024-02-202 citations

10.1007/s11655-024-3900-8

Herbal medicine foot bath for the treatment of diabetic peripheral neuropathy: protocol for a randomized, double-blind and controlled trial.

Fan G, Huang H, Lin Y, Zheng G, Tang X, Fu Y, Wei H, Zhao L, Liu Z, Wang M, Wang S, Li Q, Fang Z, Zhou Y, Dai F, Qiu X.

2018-09-1011 citations

10.1186/s13063-018-2856-4

Interventions

treatment group:footting with TangbiWaixi Decoction

control group:footting with placebo

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. patients willing to follow the doctor's treatment plan and cooperate; 3. The clinical score of Toronto more than 6 points. All patients will fill in the informed consent included.

Exclusion criteria

Exclusion criteria: 1. Exclude others causes of neuropathy, such as cervical or lumbar lesions (nerve root compression, spinal stenosis, cervical and lumbar degeneration), cerebral infarction, Guillain -Barre syndrome, severe arteriovenous vascular lesions (venous thrombosis, lymph Tube inflammation); 2. Lower extremity skin ulcers or gangrene, Lower to moderate to severe edema, or suffering from skin diseases; 3. Diabetic ketoacidosis, hyperglycemia hypertonic syndrome, diabetes lactic acidosis and other acute complications; 4. Patients with malignant tumor , or severe dysfunction of heart, liver and kidney; 5. Pregnancy or breast-feeding; 6. Participating in other similar interventions; 7. Patients with mental disorders that cant understand the nature of study, its scope, and possible outcomes , or cant follow the doctor's advice.

Design outcomes

Primary

Measure	Time frame
Toronto clinical scoring system;	—

Secondary

Measure	Time frame
nerve conduction velocity including motor and sensory conduction velocity of Median nerve and Common peroneal nerve ;blood lipid (TG, TC, LDL-C, HDL-C);Inflammatory factor (CRP, TNF-a, IL-6);European Five - dimensional Health Scale;TCM symptom score;blood glucose (FPG, 2hFBG, HbA1C);	—

Countries

China

Contacts

Public ContactGuanjie Fan

Guangdong Provincial Hospital of Chinese Medicine

13925119990@139.com+86 13925119990

Outcome results

None listed